Berenberg: Sanofi can move forward to pursue deals
Analysts at Berenberg suggest Sanofi can now shift its focus to mergers and acquisitions to bolster its late-stage drug pipeline, following an expanded collaboration with Regeneron Pharmaceuticals.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Transcript: AstraZeneca Q2 2026 Earnings Conference Call
On Monday, AstraZeneca (NASDAQ: AZN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary AstraZeneca reported a 6% growth in total revenue for the fi